Your browser doesn't support javascript.
loading
Risk of esophageal adenocarcinoma decreases with height, based on consortium analysis and confirmed by Mendelian randomization.
Thrift, Aaron P; Risch, Harvey A; Onstad, Lynn; Shaheen, Nicholas J; Casson, Alan G; Bernstein, Leslie; Corley, Douglas A; Levine, David M; Chow, Wong-Ho; Reid, Brian J; Romero, Yvonne; Hardie, Laura J; Liu, Geoffrey; Wu, Anna H; Bird, Nigel C; Gammon, Marilie D; Ye, Weimin; Whiteman, David C; Vaughan, Thomas L.
Afiliación
  • Thrift AP; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; Cancer Control Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. Electronic address: athrift@fhcrc.org.
  • Risch HA; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut.
  • Onstad L; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Shaheen NJ; Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
  • Casson AG; Department of Surgery, University of Saskatchewan, Saskatoon, Canada.
  • Bernstein L; Department of Population Sciences, Beckman Research Institute and City of Hope Comprehensive Cancer Center, Duarte, California.
  • Corley DA; Division of Research and Oakland Medical Center, Kaiser Permanente, Oakland, California.
  • Levine DM; Department of Biostatistics, University of Washington School of Public Health, Seattle, Washington.
  • Chow WH; Department of Epidemiology, MD Anderson Cancer Center, Houston, Texas.
  • Reid BJ; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Romero Y; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
  • Hardie LJ; Division of Epidemiology, University of Leeds, Leeds, United Kingdom.
  • Liu G; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre-Ontario Cancer Institute, University of Toronto, Toronto, Ontario, Canada.
  • Wu AH; Department of Preventive Medicine, University of Southern California Keck School of Medicine, Los Angeles, California.
  • Bird NC; Department of Oncology, The Medical School, University of Sheffield, United Kingdom.
  • Gammon MD; Department of Epidemiology, University of North Carolina School of Public Health, Chapel Hill, North Carolina.
  • Ye W; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Whiteman DC; Cancer Control Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Vaughan TL; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Clin Gastroenterol Hepatol ; 12(10): 1667-76.e1, 2014 Oct.
Article en En | MEDLINE | ID: mdl-24530603
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Estatura / Neoplasias Esofágicas / Adenocarcinoma Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Clin Gastroenterol Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2014 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Estatura / Neoplasias Esofágicas / Adenocarcinoma Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Clin Gastroenterol Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2014 Tipo del documento: Article